About this trial

A large ongoing randomized, open-label trial aimed at evaluating the effects of two different dietary interventions, FMD and LD, on body composition and cardiovascular (CV) biomarkers in a real word population (NCT05698654) is actually ongoing. This trial started in January 2024 will enrol 501 adult subjects between the ages of 30 and 65: 167 subjects randomized to the FMD arm with a 5-day meal program once every three months for a 6-month period (arm 1); 167 subjects randomized to follow the FMD plus a Longevity Diet program (FMD+LD) for a 6-month period (arm 2); 167 randomized to the control group (arm 3) that will continue their usual diet. On 2024,410, participants were enrolled and randomly assigned to FMD, FMD + LD, or control arm. Although preliminary data demonstrated the beneficial effects of such nutritional plans on body weight, BMI, body composition, and cardiovascular (CV) biomarkers, limited data is available on the long-term effects of these powerful nutritional interventions.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • fasting mimicking diet

Treatment groups

135 Participants
are divided into 1 treatment group

Locations

1
Ambulatorio Medico presso Biblioteca Comunale89010, VarapodioCalabria, Italy, Italy

Sponsors and collaborators

Fondazione Valter Longo

Lead sponsor

Universita degli Studi di Palermo

Collaborator

University of Calabria

Collaborator

Regione Calabria / Comune Varapodio

Collaborator

European Longevity Institute

Collaborator